- Home
- RVPH vs LTH Comparison
RVPH vs LTH Comparison
Compare RVPH & LTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVPH
- LTH
- Stock Information
- Founded
- RVPH 2006
- LTH 1992
- Country
- RVPH United States
- LTH United States
- Employees
- RVPH N/A
- LTH N/A
- Industry
- RVPH Biotechnology: Pharmaceutical Preparations
- LTH Hotels/Resorts
- Sector
- RVPH Health Care
- LTH Consumer Discretionary
- Exchange
- RVPH Nasdaq
- LTH Nasdaq
- Market Cap
- RVPH 32.8M
- LTH 6.3B
- IPO Year
- RVPH N/A
- LTH 2021
- Fundamental
- Price
- RVPH $0.36
- LTH $29.23
- Analyst Decision
- RVPH Strong Buy
- LTH Buy
- Analyst Count
- RVPH 5
- LTH 13
- Target Price
- RVPH $9.00
- LTH $34.42
- AVG Volume (30 Days)
- RVPH 2.6M
- LTH 4.3M
- Earning Date
- RVPH 08-13-2025
- LTH 07-31-2025
- Dividend Yield
- RVPH N/A
- LTH N/A
- EPS Growth
- RVPH N/A
- LTH 174.52
- EPS
- RVPH N/A
- LTH 0.96
- Revenue
- RVPH N/A
- LTH $2,730,319,000.00
- Revenue This Year
- RVPH N/A
- LTH $14.61
- Revenue Next Year
- RVPH N/A
- LTH $11.38
- P/E Ratio
- RVPH N/A
- LTH $30.24
- Revenue Growth
- RVPH N/A
- LTH 18.58
- 52 Week Low
- RVPH $0.30
- LTH $18.53
- 52 Week High
- RVPH $4.28
- LTH $34.99
- Technical
- Relative Strength Index (RSI)
- RVPH 31.07
- LTH 51.11
- Support Level
- RVPH $0.35
- LTH $28.87
- Resistance Level
- RVPH $0.40
- LTH $30.51
- Average True Range (ATR)
- RVPH 0.07
- LTH 0.96
- MACD
- RVPH -0.03
- LTH 0.17
- Stochastic Oscillator
- RVPH 15.15
- LTH 73.88
About RVPH Reviva Pharmaceuticals Holdings Inc.
Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease and Parkinson's disease psychosis and its other drug candidate is RP1208.
About LTH Life Time Group Holdings Inc.
Life Time Group Holdings Inc is a lifestyle and leisure brand offering health, fitness, and wellness experiences to a community. It is engaged in designing, building, and operating distinctive and large, multi-use sports and athletic, professional fitness, family recreation, and spa centers in a resort-like environment, principally in residential locations of metropolitan areas in the United States and Canada.